MICHAEL MURPHY, OD
Optometry at 7 Mile Rd, Livonia, MI
License number
Michigan 4901004902
Category
Optometry
Type
Optometrist
Address
Address
2
29474 7 Mile Rd, Livonia, MI 48152
1700 S Park St, Kalamazoo, MI 49001
1700 S Park St, Kalamazoo, MI 49001
Phone
(248) 615-2815
(248) 615-3310 (Fax)
(269) 342-0003
(269) 342-4284 (Fax)
(248) 615-3310 (Fax)
(269) 342-0003
(269) 342-4284 (Fax)
Personal information
See more information about MICHAEL MURPHY at radaris.comName
Address
Phone
4848 Perryville Rd, Holly, MI 48442
4908 Chippewa Ct, Owosso, MI 48867
488 N Huron Rd, Au Gres, MI 48703
4733 Catamount Trl NE, Ada, MI 49301
Professional information
Michael Murphy - Livonia, MI
Work:
On Site
Technician Office Depot - Livonia, MI
Computer Technician McDonalds - Livonia, MI
Crew Trainer
Technician Office Depot - Livonia, MI
Computer Technician McDonalds - Livonia, MI
Crew Trainer
Education:
Wayne State University - Detroit, MI
Bachelors of Science in Computer Technology Schoolcraft College - Livonia, MI
Associate of Applied Science in Computer Support Technician
Bachelors of Science in Computer Technology Schoolcraft College - Livonia, MI
Associate of Applied Science in Computer Support Technician
Alpha-Substituted Pyrimidine-Thioalkyl And Alkylether Compounds As Inhibitors Of Viral Reverse Transcriptase
US Patent:
6043248, Mar 28, 2000
Filed:
Oct 17, 1997
Appl. No.:
8/945153
Inventors:
Richard A. Nugent - Galesburg MI
Stephen T. Schlachter - Boulder CO
Michael J. Murphy - Kalamazoo MI
Joel Morris - Kalamazoo MI
Richard C. Thomas - Kalamazoo MI
Donn G. Wishka - Kalamazoo MI
Gary J. Cleek - Kalamazoo MI
David R. Graber - Kalamazoo MI
Stephen T. Schlachter - Boulder CO
Michael J. Murphy - Kalamazoo MI
Joel Morris - Kalamazoo MI
Richard C. Thomas - Kalamazoo MI
Donn G. Wishka - Kalamazoo MI
Gary J. Cleek - Kalamazoo MI
David R. Graber - Kalamazoo MI
Assignee:
Pharmacia & Upjohn Company - Kalamazoo MI
International Classification:
C07D23946, C07D23956, C07D23948, A61K 31505
US Classification:
514256
Abstract:
The subject invention relates to pyrimidine-thioalkyl and alkylether compounds of Formula (I) and pyrimidine-thioalkyl and alkylethers of Formula (IA), namely the compounds of Formula (I) where R. sub. 4 is selected from the group consisitng of --H or --NR. sub. 15 R. sub. 16 where R. sub. 15 is --H and R. sub. 16 is --H, C. sub. 1 -C. sub. 6 alkyl, NH. sub. 2 or R. sub. 15 and R. sub. 16 taken together with the --N form 1-pyrrolidino, 1-morpholino or 1-piperidino; and R. sub. 6 is selected from the group consisting of --H, or halo (preferably --Cl); with the overall proviso that R. sub. 4 and R. sub. 6 are not both --H. The compounds of Formula (IA) are useful in the treatment of individuals who are HIV positive being inhibitors of viral reverse transcriptase. ##STR1##.
Pyrimidine-Thioalkyl And Alkylether Compounds
US Patent:
5981537, Nov 9, 1999
Filed:
May 9, 1996
Appl. No.:
8/640898
Inventors:
Richard A. Nugent - Galesburg MI
Stephen T. Schlachter - Kalamazoo MI
Michael J. Murphy - Kalamazoo MI
Joel Morris - Kalamazoo MI
Richard C. Thomas - Kalamazoo MI
Donn G. Wishka - Kalamazoo MI
Fritz Reusser - Portage MI
Gary J. Cleek - Kalamazoo MI
Irene W. Althaus - Portage MI
Stephen T. Schlachter - Kalamazoo MI
Michael J. Murphy - Kalamazoo MI
Joel Morris - Kalamazoo MI
Richard C. Thomas - Kalamazoo MI
Donn G. Wishka - Kalamazoo MI
Fritz Reusser - Portage MI
Gary J. Cleek - Kalamazoo MI
Irene W. Althaus - Portage MI
Assignee:
Pharmacia & Upjohn Company - Kalamazoo MI
International Classification:
A61K 31505, A61K 31535, C07D41300, C07D23902
US Classification:
514274
Abstract:
The subject invention relates to pyrimidine-thioalkyl and alkylether compounds of Formula (I) and pyrimidine-thioalkyl and alkylethers of Formula (IA), namely the compounds of Formula (I) where R. sup. 4 is selected from the group consisting of --H or --NR. sub. 15 R. sub. 16 where R. sub. 15 is --H and R. sub. 16 is --H, C. sub. 1 -C. sub. 6 alkyl, --NH. sub. 2 or R. sub. 15 and R. sub. 16 taken together with the --N form 1-pyrrolidino, 1-morpholino or 1-piperidino; and R. sub. 6 is selected from the group consisting of --H, or halo (preferably --Cl); with the overall proviso that R. sub. 4 and R. sub. 6 are not both --H. The compounds of Formula (IA) are useful in the treatment of individuals who are HIV positive.